Autologous stem cell transplantation for severe autoimmune diseases: A 10-year experience

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 455-464

  Gualandi, F ^a   Bruno, B ^a   Van Lint, M T ^a   Luchetti, S ^a   Uccelli, A ^b   Capello, E ^b   Mancardi, G L ^b   Bacigalupo, A ^a   Marmont, A ^a,c  

^a Azienda Ospedaliera Universitaria S Martino   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Beh et's disease; BMT SCT; Multiple sclerosis; SADs; Severe autoimmune diseases; Stem cell transplant; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; THIOTEPA; THYMOCYTE ANTIBODY;

AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; MULTIPLE SCLEROSIS; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 35748930876     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.048     Document Type: Conference Paper

References (45)

1. DENMAN, A.M., A.S. RUSSEL, & E.J. DENMAN. 1969. Adoptive transfer of the disease of New Zealand Black mice to normal mouse strains. Clin. Exp. Immunol. 5: 269-272.
2. MORTON, H. & B.V. SIEGEL. 1974. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 compatible recipients of bone marrow from New Zealand Black mice. Proc. Natl. Acad. Sci. USA 71: 2162-2166.
3. REININGER, I., T. RADKIEWIECS & F. KOSCO. 1992. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZBXNZW) F1 pre-B cells. J. Exp. Med. 176: 1343-1353.
4. IKEHARA, S. 2001. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp. Hematol. 20: 11-17.
5. MARMONT, A.M. 2004. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract. Res. Clin. Haematol. 17: 223-232.
6. MARMONT, A.M. 2004. Historical perspective and rational of HSCT for autoimmune diseases. In Stem Cell Therapy for Autoimmune Disease. R.K. Burt, A.M. Marmont, Eds.: 223-231. Landes Bioscience. Georgetown, TX.
7. HINTERBERGER, W., M. HINTERBERGER-FISCHER & A.M. MARMONT. 2002. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem transplantation in human autoimmune diseases. Bone Marrow Transplant 30:753-759.
8. MARMONT, A.M., F. GUALANDI, M.T. VAN LINT, et al. 2003. Refractory Evans syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus autoimmunity effect. Bone Marrow Transplant 31: 399-402.
9. SYKES, M. & B. NIKOLIC. 2005. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435: 620-627.
10. BRENNER, M.K. 2004. Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential. Best Pract. Res. Clin. Haematol. 17: 359-374.
11. GRIFFITH, L.M., S.Z. PAVLETIC, A. TYNDALL, et al. 2005. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute -sponsored International Workshop. Bethesda, MD, March 12 and 13, 2005. Biol. Blood Marrow Transplant 11: 862-870.
12. MARMONT, A.M. 2006. Editorial. Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence. Bone Marrow Transplant 38: 1-4.
13. MARMONT, A.M., F. GUALANDI, D. OCCHINI, et al. 2006. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal haemolytic-uremic syndrome. Autoimmunity 39: 505-511.
14. BRODSKY, R.A., M. PETRI, B.D. SMITH, et al. 1998. Immunoablative high dose cyclophosphamide without stem cell rescue for refractory, severe autoimmune disease. Ann. Intern. Med. 26: 377-387.
15. PETRI, M., R.J. JONES & R. BRODSKY. 2003. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 48: 166-173.
16. EULER, H.H., A.M. MARMONT, A. BACIGALUPO, et al. 1996. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 88: 3621-3625.
17. VAN BEKKUM, D.W. 2004. Preclinical experiments. Best Pract. Res. Clin. Haematol. 17: 201-222.
18. BURT, R.K., S. SLAVIN, W.H. BURNS, et al. 2002. Induction of tolerance in autoimmune diseases by hematopoietic bone marrow transplantation: Getting closer to a cure? Blood 99: 768-784.
19. TYNDALL, A. & K. LEBLANC 2006. Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum 55: 521-525.
20. BURT, R.K. & A.M. MARMONT (eds). 2004. Stem Cell Transplantation for Autoimmune Disease. Landes Bioscience. Georgetown, TX.
21. GRATWOHL, A. & A. TYNDALL (eds). 2004. Stem cell transplantation for autoimmune disorders. Best Pract. Res. Clin. Haematol. 17: 199-374.
22. HOUGH, R.E., J.A. SNOWDEN & N. WULFFRAAT. 2004. Haemopoietic stem cell transplantation in autoimmune diseases: A European perspective. Br. J. Haematol. 128: 432-459.
23. MARMONT, A.M. 1993. Perspective. Immunoablation with stem cell rescue: A possible cure for systemic lupus erythematosus? Lupus 2: 151-156.
24. MARMONT, A.M., A. TYNDALL, A. GRATWOHL, et al. 1995. Haemopoietic precursor cell transplants for autoimmune diseases. Lancet 345: 978.
25. MARMONT, A.M., M.T. VAN LINT, F. GUALANDI, et al. 1997. Autologous marrow stem cell transplantation for systemic lupus erythematosus of long duration. Lupus 6: 545-548.
26. MARMONT, A.M., F. GUALANDI, G. PIAGGIO, et al. 2006. Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement. Bone Marrow Transplant 37: 1061-1063.
27. MARMONT, A.M., A. DOMINIETTO, F. GUALANDI, et al. 2006. Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs. Biol. Blood Marrow Transplant 12: 987-989.
28. MARMONT, A.M., F. GUALANDI, M.T. VAN LINT, et al. 2003. Refractory Evans syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 31: 399-402.
29. MANCARDI, G.L., R. SACCARDI, M. FILIPPI, THE ITALIAN GITMO-NEURO INTERGROUP ON AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE SCLEROSIS, et al. 2000. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57: 62-68.
30. FASSAS, A. & R. NASH. 2004. Multiple sclerosis. Best Pract. Res. Clin. Haematol. 17: 247-262.
31. RAIOLA, A.M., M.T. VAN LINT, T. LAMPARELLI, et al. 2000. Reduced intensity Thiotepa- Cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age. Br. J. Haematol. 109: 716-721.
32. SACCARDI, R., G.L. MANCARDI, A. SOLARI, et al. 2005. Autologous SCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 105: 2601-2607.
33. SACCARDI, R., T. KOZAK, C. BOCELLI- TYNDALL, et al. 2006. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow transplantation autoimmune diseases working party. Mult. Scler. 12.
34. MARMONT, A.M., F. GUALANDI, M.T. VAN LINT, et al. 2006. Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation. Lupus 15: 44-46.
35. BURT, R.K., A.M. MARMONT, Y. OYAMA, et al. 2006. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution frommyeloablative to lymphoablative transplant regimens. Arthritis Rheum. 54: 3750-3760.
36. GRATWOHL, A., J. PASSWEG, A. BOCELLI- TYNDALL, et al. 2005. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 35: 869-879.
37. JAYNE, D.R.W., J. PASSWEG, A.M. MARMONT, et al. 2004. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13: 108-176.
38. BURT, R.K., A. TRAYNOR, L. STATKUTE, et al. 2006. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295: 527-535.
39. ISAACS, J.D. & A. THIEL. 2004. Immune reconstitution. Best Pract. Res. Clin. Haematol. 17: 345-358.
40. MURARO, P.A. & D.C. DOUEK. 2006. Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol. 27: 61-67.
41. SUN, W., V. POPAT, G. HUTTON, et al. 2004. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 127: 996-1008.
42. MURARO, P.A., D.C. DOUEK, A. PACKLER, et al. 2005. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J. Exp. Med. 201: 805-816.
43. DE KLEER, I., B. VASTERT, M. KLEIN, et al. 2006. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 107: 1696-1702.
44. LOH, Y., Y. OYAMA, L. STATKUTE, et al. 2007. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: Role of conditioning regimen used. Blood 109: 2643-2648.
45. BLEI, G.G. 2006. Hematopoietic stem cell transoplantation in autoimmune diseases: Is the glass half full or half empty? Arthritis Rheum. 54: 3730-3734.